The latest Investing Matters Podcast episode featuring financial educator and author Jared Dillian has been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBHI.L Regulatory News (BHI)

  • There is currently no data for BHI

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Change of Name

29 Jun 2022 15:55

RNS Number : 6935Q
BMO UK High Income Trust PLC
29 June 2022
 

To: RNS

From: BMO UK High Income Trust PLC (now called CT UK High Income Trust PLC)

Date: 29 June 2022

LEI: 213800B7D5D7RVZZPV45

 

 

Change of Name

 

BMO UK High Income Trust PLC (the "Company") announces that it has changed its name to CT UK High Income Trust PLC with effect from 29 June 2022.

 

The Company's trading instrument display mnemonic ("TIDM") will change to CHI, CHIB and CHIU for the Company's Ordinary shares, B shares and Units respectively. The ISIN and SEDOL numbers will remain unchanged.

 

It is expected that the Company's shares will trade under the new name and TIDMs on the London Stock Exchange with effect from 8.00 a.m. on 30 June 2022.

 

The Company's website address will be amended to reflect the change of name and will be available at www.ctukhighincome.co.uk from 4 July 2022. 

 

Shareholders are unaffected by the change of name and existing share certificates should be retained and will remain valid. Any new share certificates issued will bear the name CT UK High Income Trust PLC. The investment policy and process remain unchanged with Philip Webster as Fund Manager.

Background

The Company's investment manager is part of BMO GAM (EMEA) which, in November 2021, was acquired and is currently being integrated into Columbia Threadneedle Investments. Columbia Threadneedle has been working hard to integrate both organisations in a considered and thoughtful way, focused on delivering the best possible outcomes for all its clients.

The combined business now has more than 2500 staff, including over 650 investment professionals based in North America, Europe and Asia. At 31 March 2022 Columbia Threadneedle managed £531 billion of client assets. The transaction also brings additional capabilities to Columbia Threadneedle in areas such as investment trusts, investment solutions, alternatives and responsible investment.

 

From 4 July 2022, the entire BMO GAM (EMEA) business will be rebranded as Columbia Threadneedle Investments, unifying the businesses under its global brand. Aligned to this date, all savings plan products and legal entities, which currently operate under the "BMO" prefix, will also use the "CT" prefix'

 

Many of the Company's shareholders invest through the BMO savings plans. With the BMO brand changing to Columbia Threadneedle Investments, the Company's Board has therefore resolved that continuing to align with the brand of its Manager, as well as the saving plans, avoids unnecessary confusion, and ensures the Company maximises the benefits resulting from broader investment by Columbia Threadneedle Investments.

 

 

For further information please contact:

 

Ian Ridge, BMO Investment Business Limited 0207 628 8000

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
CANSEEFLUEESEIM
Date   Source Headline
22nd Feb 20221:25 pmRNSNet Asset Value(s)
21st Feb 20221:29 pmRNSNet Asset Value(s)
18th Feb 20221:37 pmRNSNet Asset Value(s)
17th Feb 20221:17 pmRNSNet Asset Value(s)
17th Feb 20229:55 amRNSInvestor Presentation
16th Feb 202212:43 pmRNSNet Asset Value(s)
15th Feb 202212:55 pmRNSNet Asset Value(s)
14th Feb 20221:28 pmRNSNet Asset Value(s)
11th Feb 20221:23 pmRNSNet Asset Value(s)
11th Feb 20221:06 pmRNSNet Asset Value(s)
10th Feb 202212:59 pmRNSNet Asset Value(s)
9th Feb 20221:45 pmRNSNet Asset Value(s)
8th Feb 20221:06 pmRNSNet Asset Value(s)
7th Feb 20221:32 pmRNSNet Asset Value(s)
4th Feb 20221:13 pmRNSNet Asset Value(s)
3rd Feb 20221:13 pmRNSNet Asset Value(s)
2nd Feb 20221:18 pmRNSNet Asset Value(s)
1st Feb 20221:09 pmRNSNet Asset Value(s)
31st Jan 20221:12 pmRNSNet Asset Value(s)
28th Jan 202212:56 pmRNSNet Asset Value(s)
27th Jan 20221:01 pmRNSNet Asset Value(s)
26th Jan 20221:00 pmRNSNet Asset Value(s)
25th Jan 20221:13 pmRNSNet Asset Value(s)
24th Jan 20221:23 pmRNSNet Asset Value(s)
21st Jan 202212:52 pmRNSNet Asset Value(s)
21st Jan 202211:36 amRNSPortfolio Update
20th Jan 202212:51 pmRNSNet Asset Value(s)
19th Jan 20221:22 pmRNSNet Asset Value(s)
18th Jan 20221:16 pmRNSNet Asset Value(s)
17th Jan 202212:56 pmRNSNet Asset Value(s)
14th Jan 202212:50 pmRNSNet Asset Value(s)
13th Jan 202212:58 pmRNSNet Asset Value(s)
12th Jan 20221:48 pmRNSNet Asset Value(s)
11th Jan 20221:19 pmRNSNet Asset Value(s)
10th Jan 20221:12 pmRNSNet Asset Value(s)
7th Jan 202212:55 pmRNSNet Asset Value(s)
6th Jan 202212:46 pmRNSNet Asset Value(s)
5th Jan 20221:09 pmRNSNet Asset Value(s)
4th Jan 20223:31 pmRNSNet Asset Value(s)
31st Dec 202112:13 pmRNSNet Asset Value(s)
30th Dec 202112:54 pmRNSNet Asset Value(s)
29th Dec 20211:18 pmRNSNet Asset Value(s)
24th Dec 202111:46 amRNSNet Asset Value(s)
23rd Dec 20211:16 pmRNSNet Asset Value(s)
22nd Dec 20213:30 pmRNSPortfolio Update
22nd Dec 20211:14 pmRNSNet Asset Value(s)
21st Dec 20211:11 pmRNSNet Asset Value(s)
20th Dec 20211:48 pmRNSNet Asset Value(s)
17th Dec 20211:40 pmRNSNet Asset Value(s)
16th Dec 20211:39 pmRNSNet Asset Value(s)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.